In the world of investing, it's often said that the healthcare sector is a goldmine of opportunities. Medavail Holdings (MDVL), a player in the Consumer Staples Distribution & Retail sector of the healthcare industry, is one such opportunity that investors may want to consider. With a total revenue of $43.1M and a workforce of 279 employees, Medavail has been making strides in its market. However, it's important to note that the company has been grappling with a net income loss of $47.6M from continuing operations, which has significantly impacted its profit margin, currently standing at -1.06. Despite these challenges, Medavail's book value of 14.279 and a price to book ratio of 0.42X suggest that the stock is undervalued. This, coupled with a target price of $4, indicates potential for significant growth. However, investors should also consider the company's total debt of $7.08M and a negative enterprise value of $3.2M. In conclusion, while Medavail Holdings has some financial hurdles to overcome, its undervalued status and potential for growth make it a stock to watch in January. As always, investors should conduct their own due diligence before making any investment decisions. While some millennials may be indifferent towards the consumer staples distribution and retail sector, it's worth taking a closer look at Medavail Holdings. We will explore the potential of incorporating Medavail Holdings into your portfolio. What is the company's valuation so far in 2023? We will delve into Medavail Holdings' perspective on its valuation to provide investors with greater transparency before deciding to invest in it.
We determine the current worth of Medavail Holdings using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medavail Holdings based exclusively on its
fundamental and basic
technical indicators. By analyzing Medavail Holdings's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Medavail Holdings's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medavail Holdings. We calculate exposure to Medavail Holdings's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Medavail Holdings's related companies.
Watch out for price decline
Please consider monitoring Medavail Holdings on a daily basis if you are holding a position in it. Medavail Holdings is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Medavail Holdings stock to be traded above the $1 level to remain listed. If Medavail Holdings stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Medavail Holdings Investment Alerts
Medavail investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Medavail Holdings performance across your portfolios.Please check all
investment alerts for Medavail
Medavail Holdings Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare Medavail value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medavail Holdings competition to find
correlations between indicators driving the intrinsic value of Medavail.
Another angle On Medavail Holdings
The latest bullish price patterns experienced by current Medavail Holdings shareholders may encourage institutional investors to take a closer look at the firm as it is trading at a share price of
4.64 on
37,701 in trading volume. The company directors and management have been very successful in rebalancing the firm assets at opportune times to take advantage of
market volatility in
November. The stock standard deviation of daily returns for 90 days investing horizon is currently 11.55. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Medavail Holdings partners.
Margins Breakdown
Medavail profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Medavail Holdings itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Medavail Holdings profit margins.
| EBITDA Margin | (1.05) |
| Gross Margin | 0.0647 |
| Profit Margin | (1.19) |
Medavail Holdings Earnings Before Interest Taxes and Depreciation Amortization EBITDA is decreasing over the last 8 years. Further, Medavail Holdings Earnings before Tax is quite stable at the moment. Medavail Holdings Earnings Before Interest Taxes and Depreciation Amortization EBITDA is decreasing over the last 8 years.
The previous year's value of Medavail Holdings Earnings Before Interest Taxes and Depreciation Amortization EBITDA was -42,864,079. Further, Medavail Holdings Earnings before Tax is quite stable at the moment. "Buy when there's blood in the streets," goes the old investment adage, and Medavail Holdings (MDVL) might just be the opportunity that savvy investors have been waiting for. Despite a high probability of bankruptcy at 96.00%, the company's current ratio stands at a robust 5.58X, suggesting a strong ability to meet short-term obligations. With a market capitalization of just $7.76M, the stock is trading at a price to book ratio of 0.42X, significantly below the industry average, indicating that the stock may be undervalued. However, investors should be cautious as the company reported a net income loss of $47.6M, and an operating margin of -11.0, indicating operational inefficiencies. Despite these challenges, the company's beta of -0.59 suggests it is less volatile than the market, potentially providing a buffer in turbulent times. With a potential upside of 19.46, Medavail Holdings may be poised for remarkable growth in January, but investors should carefully consider the risks. .
Medavail Holdings to fall back in January
The recent increase in the standard deviation of Medavail Holdings, which has risen over 11.42, signifies a substantial surge in the stock's volatility. This escalated volatility, often a harbinger of a potential price correction, implies that Medavail Holdings may undergo a pullback in January. Investors are advised to exercise caution and take this heightened risk into account when making investment decisions regarding this stock. Medavail Holdings is exhibiting above-average volatility over the chosen time horizon. Investors are encouraged to thoroughly analyze Medavail Holdings independently to ensure that their intended
market timing strategies align with their expectations about the stock's volatility. Understanding different
market volatility trends can often assist investors in timing the market effectively. Proper utilization of volatility indicators allows traders to gauge Medavail Holdings' stock risk against market volatility during both bullish and bearish trends. The elevated level of volatility that accompanies bear markets can directly affect
Medavail Holdings' stock price, adding stress to investors as they witness their shares' value decline.
This typically compels investors to rebalance their portfolios by purchasing different stocks as prices drop. In conclusion, Medavail Holdings (USA Stocks:MDVL) presents a compelling investment opportunity for the month of January. The company's naive expected forecast value stands at
6.28, significantly higher than its current valuation market value of
4.64. This suggests a potential upside price of 17.84, which could provide significant returns for investors. Furthermore, the analyst overall consensus for Medavail is a 'Strong Buy', with one analyst giving a strong buy recommendation. However, investors should also consider the analyst's lowest estimated target price of 1, indicating a possible downside risk. Therefore, while the stock has the potential to go 'insane' in January, investors should exercise due diligence and consider both the potential rewards and risks associated with this investment. .
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Medavail Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com